Vol. 4 Issue 3 Part C

Background: Among women ovarian cancer the seventh-most common cancer and the eighth-most common cause of death from cancer. The typical age of diagnosis is 63. When this process begins, there may be no or only vague symptoms. Symptoms become more noticeable as the cancer progresses. With the increasing load of patients in our setup it is essential to look for serum tumor markers which can help narrow down patients who require attention. CA-125 is the most frequently used biomarker for ovarian cancer detection. Not only CA-125 helps to screen patients in certain age group but also monitor therapy. This study aims to find out the use of CA-125 as a potential tool for screening ovarian cancer in certain age groups in conjunction with other findings.